Fully Disposable Wireless Patch Sensor for Continuous Remote Patient Monitoring

Selvaraj, Nandakumar; Nallathambi, Gabriel; Moghadam, Rod; Aga, Arshan

doi:10.1109/embc.2018.8512569

Cited by 28 publications

(27 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Five studies (N=133) have been published on the VitalPatch and its previous version HealthPatch MD, which is not available anymore (VitalConnect; Table 1 ) [ 41 - 43 , 65 ]. Of them, one mixed methods study compared the HealthPatch with the ViSi Mobile [ 59 ].…”

Section: Resultsmentioning

confidence: 99%

Current Evidence for Continuous Vital Signs Monitoring by Wearable Wireless Devices in Hospitalized Adults: Systematic Review

Leenen¹,

Leerentveld²,

Dijk³

et al. 2020

J Med Internet Res

150

128

View full text Add to dashboard Cite

Background Continuous monitoring of vital signs by using wearable wireless devices may allow for timely detection of clinical deterioration in patients in general wards in comparison to detection by standard intermittent vital signs measurements. A large number of studies on many different wearable devices have been reported in recent years, but a systematic review is not yet available to date. Objective The aim of this study was to provide a systematic review for health care professionals regarding the current evidence about the validation, feasibility, clinical outcomes, and costs of wearable wireless devices for continuous monitoring of vital signs. Methods A systematic and comprehensive search was performed using PubMed/MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials from January 2009 to September 2019 for studies that evaluated wearable wireless devices for continuous monitoring of vital signs in adults. Outcomes were structured by validation, feasibility, clinical outcomes, and costs. Risk of bias was determined by using the Mixed Methods Appraisal Tool, quality assessment of diagnostic accuracy studies 2nd edition, or quality of health economic studies tool. Results In this review, 27 studies evaluating 13 different wearable wireless devices were included. These studies predominantly evaluated the validation or the feasibility outcomes of these devices. Only a few studies reported the clinical outcomes with these devices and they did not report a significantly better clinical outcome than the standard tools used for measuring vital signs. Cost outcomes were not reported in any study. The quality of the included studies was predominantly rated as low or moderate. Conclusions Wearable wireless continuous monitoring devices are mostly still in the clinical validation and feasibility testing phases. To date, there are no high quality large well-controlled studies of wearable wireless devices available that show a significant clinical benefit or cost-effectiveness. Such studies are needed to help health care professionals and administrators in their decision making regarding implementation of these devices on a large scale in clinical practice or in-home monitoring.

show abstract

Section: Resultsmentioning

confidence: 99%

Current Evidence for Continuous Vital Signs Monitoring by Wearable Wireless Devices in Hospitalized Adults: Systematic Review

Leenen¹,

Leerentveld²,

Dijk³

et al. 2020

J Med Internet Res

150

128

View full text Add to dashboard Cite

show abstract

“…This opens up more opportunities for HRV analysis in various settings, among which for instance ambulatory care. Future expansion of this concept could entail the use of wireless biosensors for continuous remote monitoring such as the VitalPatch that is able to register RR time series, together with breathing rates, skin temperature, and functional positions based on an accelerometer (47). These wireless biosensors could be the next step in monitoring therapeutic responses in chronic pain patients in a home‐setting and could perhaps prove to be more reliable parameters for pain intensity than current approaches.…”

Section: Discussionmentioning

confidence: 99%

Effects of Spinal Cord Stimulation on Heart Rate Variability in Patients With Failed Back Surgery Syndrome: Comparison Between a 2-lead ECG and a Wearable Device

Goudman

Brouns

Linderoth

et al. 2021

Neuromodulation: Technology at the Neural Interface

View full text Add to dashboard Cite

“…Other devices, already commercialized, have similar efficiency in arrhythmia detection (13)(14)(15). Wireless monitoring has been confirmed as a valuable tool to detect adverse events in high risk patients (14,(16)(17)(18)(19). Improvement in the detection of AF have also been shown (20).…”

Section: Discussionmentioning

confidence: 98%

Cardiac Ambulatory Monitoring: New Wireless Device Validated Against Conventional Holter Monitoring in a Case Series

Murali

Brugger

Rincon

et al. 2020

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Background: Cardiac arrhythmias are very common but underdiagnosed due to their transient and asymptomatic nature. An optimization of arrhythmia detection would permit to better treat patients and could substantially reduce morbidity and mortality. The SmartCardia ScaAI wireless patch is a novel CE IIa approved, single-lead electrocardiographic (ECG) ambulatory monitor designed for cardiac arrhythmias detection.Hypothesis: The accuracy of the new SmartCardia wireless patch to detect arrhythmias is comparable to the conventional Holter monitoring.Methods: Patients referred for a suspicion of arrhythmia between February and March 2020 were included in the trial. Simultaneous ambulatory ECG were recorded using a conventional 24-h Holter and the SmartCardia. The primary endpoint was the detection of cardiac arrhythmias over the total wear time of the devices, defined as premature atrial contraction (PAC), supraventricular tachycardia ≥3 beats, premature ventricular contraction (PVC), and ventricular tachycardia ≥3 beats. Conduction abnormalities, pause ≥2 s and atrioventricular block (AVB), were also tracked. McNemar's test was used to compare the matched pairs of data from both devices.Results: A total of 40 patients were included in the trial. Over the total wear time, there was no significant difference between the devices for ventricular and supraventricular arrhythmias detection. Pauses and AVB were equally identified by the two devices in three patients.Conclusion: Over the total wear time, the SmartCardia device showed an accuracy to detect arrhythmia similar to the 24-h Holter monitoring: single-lead, adhesive-patch monitoring might become an interesting alternative to the conventional Holter monitoring.

show abstract

Fully Disposable Wireless Patch Sensor for Continuous Remote Patient Monitoring

Cited by 28 publications

References 8 publications

Current Evidence for Continuous Vital Signs Monitoring by Wearable Wireless Devices in Hospitalized Adults: Systematic Review

Current Evidence for Continuous Vital Signs Monitoring by Wearable Wireless Devices in Hospitalized Adults: Systematic Review

Effects of Spinal Cord Stimulation on Heart Rate Variability in Patients With Failed Back Surgery Syndrome: Comparison Between a 2-lead ECG and a Wearable Device

Cardiac Ambulatory Monitoring: New Wireless Device Validated Against Conventional Holter Monitoring in a Case Series

Contact Info

Product

Resources

About